Declining Trends in HTLV-I Prevalence among Blood Donors in Japan

Internal Medicine

Volumn 40, Issue 1, 2001, Pages 1-2

  Yamaguchi, Kazunari ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

ATL; HTLV I carrier

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; BLOOD; BLOOD DONOR; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; EPIDEMIOLOGY; FEMALE; GENETICS; HETEROZYGOTE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; NOTE; PROVIRUS; VIRUS LOAD;

ADOLESCENT; ADULT; BLOOD DONORS; CARRIER STATE; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; PROVIRUSES; SEROEPIDEMIOLOGIC STUDIES; VIRAL LOAD;

EID: 0035218749     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.1     Document Type: Article

References (10)

1. Yamaguchi K. Human T-lymphotropic virus type I in Japan. Lancet 343: 213–216, 1994.
2. Inaba S, Okochi K, Sato H, et al. Efficacy of donor screening for HTLV-I and the natural history of transfusion-transmitted infection. Transfusion 39: 1104–1110, 1999.
3. Murphy EL, Watanabe K, Nass CC, Ownby H, Williams A, Nemo G. Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States. J Infect Dis 180: 1777–1783, 1999.
4. Murphy EL, Glynn SA, Fridey J, et al. and Retrovirus Epidemiology Donor Study (REDS) Study Group. Increased prevalence of infectious diseases and other adverse outcomes in human T-lymphotropic virus types I- and II-infected blood donors. J Infect Dis 176: 1468–1475, 1997.
5. Rouet F, Foucher C, Rabier M, et al. Human T-lymphotropic virus type I among blood donors from Guadeloupe: donation, demographic, and biologic characteristics. Transfusion 39: 639–644, 1999.
6. Yamaguchi K, Nishimura Y, Kusumoto Y, et al. Declining trends of HTLV-I prevalence among blood donors in Kumamoto, Japan. J Acqir Immune Defic Syndr 5: 533–534, 1992.
7. Oguma S, Imamura Y, Kusumoto Y. et al. Stable human T-lymphotropic virus type I carrier rates for 7 years among a teenaged blood donor cohort of 1986 in Kumamoto, Japan. Leuk Res 19: 567–571, 1995.
8. Chiyoda S, Kinoshita K, Egawa S, Inoue J, Watanabe K, Ifuku M. Decline in the positive rate of human T-lymphotropic virus type-1 (HTLV-1) antibodies among blood donors in Nagasaki. Intern Med 40: 14-17, 2001.
9. Etoh K, Yamaguchi K, Tokudome S, et al. Rapid quantification of HTLV-I provirus load: detection of monoclonal proliferation of HTLV-I-infected cells among blood donors. Inf J Cancer 81: 859–864, 1999.
10. Guiltinan AM, Murphy EL, Horton JA, Nass CC, McEntire RL, Watanabe K. Psychological distress in blood donors notified of HTLV-I/II infection. Retrovirus Epidemiology Donor Study. Transfusion 38: 1056–1062, 1998.